Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs - Concepedia

Concepedia

Publication | Open Access

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

DOI Full Paper Access

261

Citations

1

References

2020

Year

Alyson Haslam, Jennifer Gill, Vinay Prasad

JAMA Network Open

Abstract

This cross-sectional study estimates the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs.

References

	Year	Citations

Page 1